Actavis Laboratories UT, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 577 Chipeta Way, Salt Lake City, Utah (UT) 84108, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 1000117147 · DUNS 079589880
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-09-19
- OAIDrug Quality Assurance2024-03-19
- VAIDrug Quality Assurance2021-08-20
- NAIBioresearch Monitoring2018-08-02
- NAIDrug Quality Assurance2017-10-25
- NAIDrug Quality Assurance2015-12-08
- VAIDrug Quality Assurance2014-10-17
- VAIDrug Quality Assurance2014-01-17
- VAIDrug Quality Assurance2012-12-14
- VAIDrug Quality Assurance2012-06-08
- VAIDrug Quality Assurance2011-01-14
- NAIDrug Quality Assurance2009-04-24
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- Diclofenac SodiumActavis Pharma, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.